Associations between annualized relapse rate and long-term exposure to subcutaneous interferon β-1a in the Prevention of Relapses and disability by Interferon β-1a Subcutaneously in Multiple Sclerosis (PRISMS) long-term follow-up study

被引：0
|
作者：
Uitdehaag, B.
Constantinescu, C.
Cornelisse, P.
Jeffery, D.
Kappos, L.
Li, D.
Sandberg-Wollheim, M.
Traboulsee, A.
Verdun, E.
Rivera, V.
机构：
[1] Univ Med Ctr, Amsterdam, Netherlands
[2] Univ Nottingham, Nottingham NG7 2RD, England
[3] Merck Serono SA, Geneva, Switzerland
[4] Wake Forest Univ, Winston Salem, NC 27109 USA
[5] Univ Hosp, Basel, Switzerland
[6] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada
[7] Univ Hosp, Lund, Sweden
[8] Baylor Coll Med, Houston, TX 77030 USA
来源：
JOURNAL OF NEUROLOGY | 2010年 / 257卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P456
引用
收藏
页码：S148 / S148
页数：1
相关论文
共 50 条
  • [1] The multiple sclerosis PRISMS study:: Prevention of relapses and disability by interferon β-1a subcutaneously in multiple sclerosis
    Ebers, GC
    Oger, J
    Paty, D
    Li, D
    Freedman, M
    Hartung, HP
    Hommes, O
    McLeod, J
    Sandberg, M
    Wikström, J
    Carton, H
    Hughes, RAC
    Pancelius, M
    Medaer, R
    Blumhardt, L
    Barnes, D
    Bertelsmann, F
    Chofflon, M
    Kappos, L
    King, J
    Newsom-Davis, J
    Sindic, C
    Uitehaag, B
    Van Doom, P
    Bates, D
    Dupont, F
    Galazka, A
    Hyde, R
    Pernin, MO
    Abdul-Ahad, A
    ANNALS OF NEUROLOGY, 1997, 42 (06) : 986 - 986
  • [2] Pharmacodynamic Biomarkers of Interferon β-1a: Assessment in Patients Receiving Long-Term Treatment with Subcutaneous Interferon β-1a
    Freedman, Mark
    Wojcik, Jerome
    D'Antonio, Mauro
    Hyvert, Yann
    Stinchi, Sofia
    D'Urso, Vittorio
    Dangond, Fernando
    NEUROLOGY, 2020, 94 (15)
  • [3] Long-term treatment with interferon β-1a evaluated
    Hausmann, Ralph
    FORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE, 2007, 75 (01) : 9 - 9
  • [4] Long-term clinical benefits from subcutaneous interferon-beta-1a: a phased analysis of the PRISMS long-term follow-up study
    Traboulsee, A.
    Li, D.
    Kappos, L.
    MULTIPLE SCLEROSIS JOURNAL, 2006, 12 : S192 - S192
  • [5] Pharmacodynamic biomarkers of interferon β-1a: assessment in patients receiving long-term treatment with subcutaneous interferon β-1a in REFLEX and REFLEXION
    Freedman, M. S.
    Wojcik, J.
    D'Antonio, M.
    Hyvert, Y.
    Stinchi, S.
    D'Urso, V.
    Dangond, F.
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 769 - 770
  • [6] PRISMS-4:: Long-term efficacy of interferon-β-1a in relapsing MS
    Francis, G
    Hughes, R
    King, J
    Mitchell, P
    Joubert, J
    McLeod, J
    Parker, G
    Pollard, J
    Sindic, CJM
    Duprez, T
    Medaer, R
    Broeckx, J
    Vanroose, E
    Carton, H
    Wilms, G
    Rice, G
    Ebers, G
    Lee, DH
    Freedman, M
    Nelson, R
    Rabinovitch, H
    Christie, S
    Avruch, L
    Oger, J
    Paty, DW
    Li, D
    Wikström, J
    Salonen, OLM
    Panelius, M
    Erälinna, J
    Sonninen, P
    Rieckmann, P
    Hahn, D
    Flachenecker, P
    Hartung, HP
    Uitdehaag, B
    Bertelsmann, FW
    Barkhof, F
    Hommes, OR
    Jongen, PJH
    Van Doorn, PA
    Tanghe, HLG
    Sandberg-Wollheim, M
    Larsson, EM
    Lönntoft, M
    Sallerfors, S
    Kappos, L
    Lienert, C
    Radü, EW
    Chofflon, M
    NEUROLOGY, 2001, 56 (12) : 1628 - 1636
  • [7] Interferon-β-1b therapy in multiple sclerosis:: long-term follow-up
    Vermersch, R
    Dufourd-Delalande, S
    Waucquier, N
    Ferriby, D
    Stojkovic, T
    Hautecoeur, R
    de Seze, J
    MULTIPLE SCLEROSIS, 2004, 10 (7032): : S246 - S246
  • [8] Treatment of early-onset multiple sclerosis with intramuscular interferonβ-1a:: long-term results
    Ghezzi, A.
    Amato, M. P.
    Capobianco, M.
    Gallo, P.
    La Mantia, L.
    Marrosu, M. G.
    Martinelli, V.
    Milani, N.
    Milanese, C.
    Moiola, L.
    Patti, F.
    Pozzilli, C.
    Trojano, M.
    Zaffaroni, M.
    Comi, G.
    NEUROLOGICAL SCIENCES, 2007, 28 (03) : 127 - 132
  • [9] Treatment of early-onset multiple sclerosis with intramuscular interferonβ-1a: long-term results
    A. Ghezzi
    M. P. Amato
    M. Capobianco
    P. Gallo
    M. G. Marrosu
    V. Martinelli
    C. Milanese
    L. Moiola
    N. Milani
    L. La Mantia
    F. Patti
    C. Pozzilli
    M. Trojano
    G. Comi
    M. Zaffaroni
    Neurological Sciences, 2007, 28 : 127 - 132
  • [10] Continuous versus non-continuous subcutaneous interferon β-1a treatment in relapsing-remitting multiple sclerosis: long-term data from the PRISMS study
    Uitdehaag, B.
    Kappos, L.
    Verdun, E.
    Gardner, J.
    JOURNAL OF NEUROLOGY, 2009, 256 : S122 - S123
12345